Search
Close this search box.

Risen Pharma Announces Initiation of Phase 2 Clinical Trial of RP902 for Mild Cognitive Impairment Due to Alzheimer’s Disease

SHANGHAI, May 19, 2026 (GLOBE NEWSWIRE) — Risen Pharma, a clinical-stage biotech company focusing on the development and commercialization of high-need, patient-accessible therapeutics, today announced the initiation of a Phase 2 clinical study in China of RP902, an oral small-molecule drug developed to address significant unmet medical needs in patients

Bitget Introduces Delta Neutral Mode for Hedged Trading Strategies

Bitget Introduces Delta Neutral Mode for Hedged Trading Strategies VICTORIA, Seychelles, May 18, 2026 (GLOBE NEWSWIRE) — Bitget, the world’s largest Universal Exchange (UEX), has introduced Delta Neutral Mode within its Unified Trading Account, adding a new risk management feature designed for traders using hedging and arbitrage strategies across spot,

Bitget Enters Mexico Market With SAT and UIF Registration

Bitget Enters Mexico Market With SAT and UIF Registration VICTORIA, Seychelles, May 18, 2026 (GLOBE NEWSWIRE) — Bitget, the world’s largest Universal Exchange (UEX) has successfully completed key registrations in Mexico to operate within the country’s current virtual asset framework. With the completion of these registrations, Bitget now looks to

Bitget IPO Prime Taps Into $4T AI Opportunity With OpenAI

Bitget IPO Prime Taps Into $4T AI Opportunity With OpenAI VICTORIA, Seychelles, May 18, 2026 (GLOBE NEWSWIRE) — Bitget, the world’s largest Universal Exchange (UEX), has added OpenAI (preOPAI) as the second listing on its IPO Prime platform, extending pre-IPO access to one of the most closely watched companies in

About Us

Promoting revolutionary values and uniting movements for South Africa’s economic freedom.

Newsletter

Enter your email address below to subscribe to my newsletter